Your browser doesn't support javascript.
Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned.
Bagaria, Jayshree; Jansen, Tessa; Marques, Diogo Fp; Hooiveld, Mariette; McMenamin, Jim; de Lusignan, Simon; Vilcu, Ana-Maria; Meijer, Adam; Rodrigues, Ana-Paula; Brytting, Mia; Mazagatos, Clara; Cogdale, Jade; van der Werf, Sylvie; Dijkstra, Frederika; Guiomar, Raquel; Enkirch, Theresa; Valenciano, Marta.
  • Bagaria J; Public Health Scotland, Glasgow, Scotland.
  • Jansen T; Nivel, Utrecht, The Netherlands.
  • Marques DF; Epiconcept, Paris, France.
  • Hooiveld M; Nivel, Utrecht, The Netherlands.
  • McMenamin J; Public Health Scotland, Glasgow, Scotland.
  • de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
  • Vilcu AM; Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom.
  • Meijer A; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
  • Rodrigues AP; National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Brytting M; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
  • Mazagatos C; The Public Health Agency of Sweden, Stockholm, Sweden.
  • Cogdale J; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.
  • van der Werf S; Health Security Agency, London, United Kingdom.
  • Dijkstra F; Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Molecular Genetics of RNA viruses unit, National Reference Center for Respiratory Viruses, Paris, France.
  • Guiomar R; National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Enkirch T; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
  • Valenciano M; The Public Health Agency of Sweden, Stockholm, Sweden.
Euro Surveill ; 27(26)2022 06.
Article in English | MEDLINE | ID: covidwho-1923991
ABSTRACT
As the COVID-19 pandemic began in early 2020, primary care influenza sentinel surveillance networks within the Influenza - Monitoring Vaccine Effectiveness in Europe (I-MOVE) consortium rapidly adapted to COVID-19 surveillance. This study maps system adaptations and lessons learned about aligning influenza and COVID-19 surveillance following ECDC / WHO/Europe recommendations and preparing for other diseases possibly emerging in the future. Using a qualitative approach, we describe the adaptations of seven sentinel sites in five European Union countries and the United Kingdom during the first pandemic phase (March-September 2020). Adaptations to sentinel systems were substantial (2/7 sites), moderate (2/7) or minor (3/7 sites). Most adaptations encompassed patient referral and sample collection pathways, laboratory testing and data collection. Strengths included established networks of primary care providers, highly qualified testing laboratories and stakeholder commitments. One challenge was the decreasing number of samples due to altered patient pathways. Lessons learned included flexibility establishing new routines and new laboratory testing. To enable simultaneous sentinel surveillance of influenza and COVID-19, experiences of the sentinel sites and testing infrastructure should be considered. The contradicting aims of rapid case finding and contact tracing, which are needed for control during a pandemic and regular surveillance, should be carefully balanced.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / COVID-19 Type of study: Observational study / Qualitative research Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: 1560-7917.ES.2022.27.26.2100864

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / COVID-19 Type of study: Observational study / Qualitative research Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: 1560-7917.ES.2022.27.26.2100864